- Author:
Rui KAN
1
;
Rui ZHONG
1
;
Jing LIU
1
;
Zhi-Gui WU
1
;
Cai-Ying PENG
1
;
Hong CHEN
1
;
Xiao-Mei FU
1
;
Zhi-Gui WU
2
;
Xiao-Mei FU
2
Author Information
- Publication Type:Journal Article
- Keywords: acute promyelocytic leukemia; apoptosis; arsenic trioxide; methylation; nephrotoxicity; oxidative stress
- From: Chinese Pharmacological Bulletin 2022;38(2):177-180
- CountryChina
- Language:Chinese
- Abstract: Aim Arsenic trioxide (ATO, As203 ) can effectively treat acute promyelocyte leukemia (APL) and other malignant tumors.However.ATO has been found to have nephrotoxic effects during the treatment process, which limits the clinical application of ATO.Studies have shown that the use of ATO can interfere with the body's oxidation, causing to oxidative stress, damage DNA repair pathways, and induce DNA mutations.leading to cell cancer.This is currently one of the important mechanisms of ATO nephrotoxicity.Apoptosis, DNA methyl a- tion caused by ATO are also causes of nephrotoxicity.This article summarizes the research and prevention of ATO nephrotoxicity mechanism.